AvePoint (NASDAQ: AVPT) chair’s trusts disclose planned stock sales

Rhea-AI Filing Summary

AvePoint, Inc. insider entities reported planned stock sales. Trusts and LLCs associated with Executive Chairman and director Gong Xunkai sold 32,002 shares of common stock on January 12, 2026 at $13.66 per share and 27,998 shares on January 13, 2026 at $13.39 per share. Both transactions were indirect, reported as "Held by trusts and LLCs."

After these sales, entities associated with Mr. Gong beneficially owned 14,948,666 shares and 14,920,668 shares, respectively, on an indirect basis. The sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person on June 22, 2025, and the report notes that he may be deemed to beneficially own certain affiliate- and trust-held shares while disclaiming beneficial ownership except to the extent of his pecuniary interest.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gong Xunkai

(Last) (First) (Middle)

C/O AVEPOINT, INC.

525 WASHINGTON BOULEVARD, SUITE 1400

(Street)

JERSEY CITY NJ 07310

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AvePoint, Inc. [ AVPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
01/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/12/2026		S		32,002(1)	D	$13.66	14,948,666	I	Held by trusts and LLCs
Common Stock	01/13/2026		S		27,998(1)	D	$13.39	14,920,668(2)	I	Held by trusts and LLCs

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 22, 2025.

2. Includes (i) 3,965,953 shares held by Mr. Gong's affiliate Giocoso Holdings LLC, (ii) 459,929 shares held by Mr. Gong's affiliate Cadenza Holdings LLC, (iii) 170,465 shares held by Mr. Gong's affiliate Vivace Holdings LLC, each of which Mr. Gong may be deemed to beneficially own, (iv) 2,011,112 shares held by The Purple Harbor Trust, for which Mr. Gong is the trustee, (v) 2,011,112 shares held by The Purple Cove Trust, for which Mr. Gong is the trustee, and (vi) 6,302,097 shares held by G Sonata Trust, for which Mr. Gong is a trustee. The Reporting Person disclaims beneficial ownership with respect to the shares held by each trust and LLC, except to the extent his pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.

	/s/ Brian Michael Brown, Attorney-in-Fact	01/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the insider in this AvePoint (AVPT) Form 4 filing and what is their role?

The reporting person is Gong Xunkai, who serves as a director and Executive Chairman of AvePoint, Inc. The Form 4 indicates he is not marked as a 10% owner but reports indirect holdings through various trusts and LLCs.

How many AvePoint (AVPT) shares were sold and on which dates?

Affiliated trusts and LLCs associated with Executive Chairman Gong Xunkai sold 32,002 shares of common stock on January 12, 2026 at $13.66 per share and 27,998 shares on January 13, 2026 at $13.39 per share.

Were the AvePoint (AVPT) insider stock sales made under a Rule 10b5-1 trading plan?

Yes. A footnote states that the sale transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 22, 2025.

Are the AvePoint (AVPT) shares held directly by Gong Xunkai or through entities?

The reported holdings and sales are classified as indirect, described as "Held by trusts and LLCs." A footnote explains that the amounts include shares held by affiliates Giocoso Holdings LLC, Cadenza Holdings LLC, Vivace Holdings LLC, and several trusts for which Mr. Gong serves as trustee or is a trustee.

How many AvePoint (AVPT) shares were beneficially owned after the reported transactions?

Following the January 12, 2026 sale, entities associated with Mr. Gong beneficially owned 14,948,666 shares of AvePoint common stock. After the January 13, 2026 sale, the beneficially owned amount reported was 14,920,668 shares, all reported as indirectly held by trusts and LLCs.

What beneficial ownership disclaimer does the AvePoint (AVPT) Form 4 include?

The filing states that Mr. Gong disclaims beneficial ownership with respect to the shares held by each trust and LLC, except to the extent of his pecuniary interest, and that including these shares in the report shall not be deemed an admission of beneficial ownership of all reported shares for Section 16 or any other purpose.